Skip to Content
Commentary

The Week Ahead: Ringing in the New Decade With Earnings From Walgreens and More

Bed Bath & Beyond, Constellation Brands, Commercial Metals, and more slated for earnings this week.

Mentioned: , , , , , ,

We enter the first full week of the new decade; earnings reports and economic data will begin pouring in for fourth quarter. For next week’s earning releases, we are watching for Bed Bath & Beyond (BBBY), Constellation Brands (STZ), and Walgreens (WBA), all slated to report on Wednesday.

Bed Bath & Beyond had made what we believe were overdue changes across its leadership team late last year. These changes were sweeping indeed: The firm announced the departures of its chief merchandising officer, chief marketing officer, chief digital officer, chief legal officer, and chief administrative officer as CEO Mark Tritton settled into his role. Our analysts note that Tritton, with his extensive past career at Target, should see a healthy interest piqued for these newly opened roles. We maintain our fair value estimate of $11.40 and maintain that shares are overvalued. However, if the new plan can halt market share deceleration and set Bed Bath & Beyond back on track to gain clout with consumers, we could reconsider our negative moat trend rating.

Jess Liu does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.